MASI
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Clairity raised $43 million in Series B to launch first FDA-authorized AI platform for breast cancer risk predictionNov 14, 2025
- New study finds that using Masimo technologies to continuously monitor general floor patients reduces costsSep 17, 2025
- Masimo O3® regional oximetry receives FDA clearance for expanded indication of its unique delta hemoglobin parametersAug 19, 2025